We are live on ! Find out more
GNPX icon

Genprex

25 hedge funds and large institutions have $9.78M invested in Genprex in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

40% more call options, than puts

Call options by funds: $447K | Put options by funds: $319K

0% more ownership

Funds ownership: 0%0% (+0%)

11% less funds holding

Funds holding: 2825 (-3)

38% less capital invested

Capital invested by funds: $15.8M → $9.78M (-$6.02M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
2
Closed
7
Calls
$447K
Puts
$319K
Net Calls
+$128K
Net Calls Change
+$315K
Name Holding Trade Value Shares
Change
Change in
Stake
HI
51
Harbour Investments
Wisconsin
-$6K
MAM
52
Meeder Asset Management
Ohio
-$29K
Nisa Investment Advisors
53
Nisa Investment Advisors
Missouri
-$6
SPIA
54
Steward Partners Investment Advisory
New York
-$4K

GNPX Hedge Fund Activity: Q4 2021 in Review

25 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2021, worth a combined $9.78M — down 38% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GNPX and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $1.5M. The largest seller was Ergoteles, exiting entirely with an estimated $200K sold.

  • 25 institutional investors held Genprex (GNPX) as of Q4 2021, down from 28 in Q3 2021.
  • Funds reported $9.78M of Genprex stock for Q4 2021, down 38% quarter-over-quarter.
  • 4 funds opened new Genprex positions in Q4 2021 and 7 closed out, a net change of -3 holders.
  • The largest Genprex buyer in Q4 2021 was Morgan Stanley, an estimated $1.5M added.
  • The largest Genprex seller in Q4 2021 was Ergoteles, an estimated $200K sold.

Based on aggregated 13F filings for Q4 2021.